The Origins of Sodium Thiosulfate as an Otoprotective Agent - Extended Interview

At the 49th Congress of the International Society of Paediatric Oncology held in Washington D.C., October 12-15, Rare Disease Report spoke with Edward Neuwelt, MD of Oregon Health & Science University about the origins of developing sodium thiosulfate as a possible means to protect against chemotherapy-induced hearing loss.

As Dr Neuwelt explains in this video, it was a series of scientific breakthroughs that began with a curious husband trying to understand why his wife lost her hearing following chemotherapy.